Lianhua Qingwen (simplified Chinese: 连花清瘟; traditional Chinese: 連花清瘟; lit. 'medicine using Forsythia suspensa and Lonicera japonica to clear epidemic', [1] LHQW) is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza.

Nov 28, 2023 · In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes decreased the level of clinical evidence. To evaluate the efficacy and safety of LHQW capsule in adults with mild-to-moderate COVID-19.

Lianhua Qingwen (LHQW) has been widely used in China and overseas Chinese, which had some advantages in the treatment of COVID-19. To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis.

Lianhua Qingwen (LHQW) is a new Chinese patent medicine for the treatment of cold and flu approved by the China’s National Medical Products Administration (NMPA).

The Chinese prescription Lianhua Qingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complem.

Apr 1, 2021 · Lianhua Qingwen has antipyretic, anti-inflammatory, cough-relieving and phlegm-resolving effects, and can alleviate influenza-like symptoms, as well as regulate immunity to enhance the body's ability to resist disease and enhance rehabilitation.

Oct 1, 2021 · Lianhua-Qingwen capsule (LQC) is a commonly used Traditional Chinese Medicine (TCM) in China and has 11 herb components. The main active ingredient can target specific molecules and perform many clinic treatment roles.

Mar 1, 2021 · Therefore, our study aimed to assess the efficacy and safety of Lianhuaqingwen (LH) in treating patients with COVID-19 by a systematic review and meta-analysis. We conducted the literature search using six electronic databases from December 1, 2019, to June 2, 2020.

Current evidence shows that Lianhua Qingwen capsule is more effective and safer than Oseltamivir, Ribavirin and Ankahuangmin capsules. Due to the low quality of the clinical research, the accuracy of this conclusion needs to be conducted to verify.

Efficacy and safety of Lianhua Qingwen capsules, a repurposed Chinese herb, in patients with Coronavirus disease 2019: A multicenter, prospective, randomized controlled trial [Phytomedicine 85 (2021) 153242]